GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,517 Cr | ₹1,559 Cr | ₹871 Cr | ₹1,075 Cr | ₹671 Cr |
What is the latest Sundry Debtors ratio of GLAND PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹1,517 Cr |
Mar2024 | ₹1,559 Cr |
Mar2023 | ₹871 Cr |
Mar2022 | ₹1,075 Cr |
Mar2021 | ₹671 Cr |
How is Sundry Debtors of GLAND PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹1,517 Cr | -2.70 | |
Mar2024 | ₹1,559 Cr | 78.87 | |
Mar2023 | ₹871 Cr | -18.93 | |
Mar2022 | ₹1,075 Cr | 60.19 | |
Mar2021 | ₹671 Cr | - |
Compare Sundry Debtors of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹32,569.4 Cr | -2% | 1.8% | 12.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,348.0 Cr | -1.3% | -1.8% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,840.0 Cr | -2% | -4.2% | 11% | Stock Analytics | |
CIPLA | ₹124,222.0 Cr | -2.6% | -4% | -6.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,346.0 Cr | 1.4% | -1.5% | 5.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,437.0 Cr | -1.8% | 1.1% | -0.2% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -2% |
1.8% |
12.4% |
SENSEX | -1.2% |
0.5% |
-1.8% |
You may also like the below Video Courses